XERS
Xeris Pharmaceuticals Inc
13.10$
+25.0%
vs. previous close
Closing price · As of: Nov 5, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Xeris Pharmaceuticals Inc (XERS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 11/05/2026 | Current report (8-K) | Xeris Biopharma Holdings, Inc. (XERS): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 11/05/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 11/02/2026 | Current report (8-K) | Xeris Biopharma Holdings, Inc. (XERS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 11/02/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 10/14/2026 | Current report (8-K) | Xeris Biopharma Holdings, Inc. (XERS): Other Events | View report ↗ |
| 10/01/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/28/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/09/2026 | Current report (8-K) | Xeris Biopharma Holdings, Inc. (XERS): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/12/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/06/2026 | Current report (8-K) | Xeris Biopharma Holdings, Inc. (XERS): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/31/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/17/2026 | Current report (8-K) | Xeris Biopharma Holdings, Inc. (XERS): Unregistered Sales of Equity Securities; Other Events | View report ↗ |
| 07/07/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 07/06/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.